Breakthrough stroke drug aims to prevent clots without causing bleeding
NCT ID NCT06813651
Summary
This study is testing whether adding a new drug called TBO-309 to standard stroke treatment helps patients with a specific type of severe artery blockage. The drug aims to prevent blood clots from forming in newly placed artery stents while minimizing the risk of dangerous bleeding in the brain. Researchers will enroll 78 stroke patients who are undergoing emergency procedures to remove blockages and place stents.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
John Hunter Hospital
RECRUITINGNewcastle, New South Wales, 2305, Australia
Contact Email: •••••@•••••
Contact
-
Royal North Shore Hospital
NOT_YET_RECRUITINGSt Leonards, New South Wales, 2065, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.